Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 629: 122411, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36402288

ABSTRACT

Unmanagable bleeding during combats, road accidents, and intraoperative or external injuries causes a significant rise in mortality. Any biomaterial that can intensify hemostasis, and reduce complications, can reduce mortality and increase the survivability of the subjects. In the present research, we attempted to develop a multifunctional surgical sealant (MfSS) by integrating fast disintegrating film (FDF), nanoporous fibers reinforced composite scaffold (NFRCS), and a flexible silicon layer (FSL). By integrating FDF, NFRCS, and FSL, MfSS was developed. MfSS comprises four layers: two FDFs, one NFRCS, and one FSL. The FSL was surface coated with tissue adhesive glue that retains the MfSS at the application and controls the pressure excited by the blood. The multi-functionality of the MfSS was attained by loading tranexamic acid (TXA) and Epigallocatechin gallate (EGCG) in FDF. The developed FDFs rapidly disintegrate at the application site in the blood pool, help attain high drug concentrations at the application site, and prevent drug washout because of blood. The in vitro characterization studies confirm the possibility of developing the MfSS with four different layers and FDF disintegration in citrated rat blood. The in vivo BCT assay confirms the MfSS activates and intensifies the blood coagulation process in two animal models. The MfSS could regulate the microenvironment, and TXA and EGCG loaded in the FDF could act at the cellular level, resulting in better wound healing in the excision wound model.


Subject(s)
Patient Safety , Tranexamic Acid , Animals , Rats , Blood Coagulation , Biocompatible Materials , Biological Assay , Silicon
2.
Sci Rep ; 12(1): 8198, 2022 05 17.
Article in English | MEDLINE | ID: mdl-35581396

ABSTRACT

Unmanageable bleeding is one of the significant causes of mortality. Attaining rapid hemostasis ensures subject survivability as a first aid during combats, road accidents, surgeries that reduce mortality. Nanoporous fibers reinforced composite scaffold (NFRCS) developed by a simple hemostatic film-forming composition (HFFC) (as a continuous phase) can trigger and intensify hemostasis. NFRCS developed was based on the dragonfly wing structure's structural design. Dragonfly wing structure consists of cross-veins and longitudinal wing veins inter-connected with wing membrane to maintain the microstructural integrity. The HFFC uniformly surface coats the fibers with nano thickness film and interconnects the randomly distributed cotton gauge (Ct) (dispersed phase), resulting in the formation of a nanoporous structure. Integrating continuous and dispersed phases reduce the product cost by ten times that of marketed products. The modified NFRCS (tampon or wrist band) can be used for various biomedical applications. The in vivo studies conclude that the developed Cp NFRCS triggers and intensifies the coagulation process at the application site. The NFRCS could regulate the microenvironment and act at the cellular level due to its nanoporous structure, which resulted in better wound healing in the excision wound model.


Subject(s)
Hemostatics , Nanopores , Odonata , Animals , Blood Coagulation , Hemostasis , Hemostatics/pharmacology , Odonata/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...